A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06718621 · RECRUITING
Trial details
- NCT number
- NCT06718621
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-12
- Primary completion
- 2026-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.